Insider Trading Summary for Supernus Pharmaceuticals, Inc. (SUPN): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
27-Feb-24 5:03 PM View:	23-Feb-24 Grant 0	Hudson Frederick M. Director		Supernus Pharmaceuticals, Inc. - SUPN	6% 34.87K to 37.12K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 5:02 PM View:	23-Feb-24 Grant 0	Siebert John M Director		Supernus Pharmaceuticals, Inc. - SUPN	5% 84.06K to 87.94K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 5:04 PM View:	23-Feb-24 Grant 0	Newhall Charles W III Director		Supernus Pharmaceuticals, Inc. - SUPN	8% 112.13K to 120.97K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 5:04 PM View:	23-Feb-24 Grant 0	Gemayel Georges Director		Supernus Pharmaceuticals, Inc. - SUPN	29% 13.31K to 17.2K	0	0	--	--	Show Txns Hide Txns

25-Mar-24 5:00 PM View:	21-Mar-24 Planned Option Sale ($511.68K)	Bhatt Padmanabh P. Sr. VP of IP, CSO		Supernus Pharmaceuticals, Inc. - SUPN	81% 4.75K to 8.57K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 5:04 PM View:	23-Feb-24 Grant 0	Barlow Carrolee Director		Supernus Pharmaceuticals, Inc. - SUPN	29% 13.31K to 17.2K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 5:00 PM View:	28-Feb-24 Payment of Exercise ($469.06K)	Khattar Jack A. President, CEO Director		Supernus Pharmaceuticals, Inc. - SUPN	4% 1.87M to 1.94M	0	0	--	--	Show Txns Hide Txns

27-Feb-24 5:00 PM View:	23-Feb-24 Payment of Exercise ($14.09K)	Martin Tami Tillotson Sr. V.P., Regulatory Affairs		Supernus Pharmaceuticals, Inc. - SUPN	(4%) 90.38K to 86.93K	0	($162.22K) (6%)	--	$31.59	Show Txns Hide Txns

27-Feb-24 5:01 PM View:	23-Feb-24 Payment of Exercise ($38.18K)	Dec Timothy C Senior Vice-President & CFO		Supernus Pharmaceuticals, Inc. - SUPN	287% 1.86K to 7.19K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 5:01 PM View:	28-Feb-24 Payment of Exercise ($12.85K)	Mottola Frank SVP, Quality, GMP, Ops, IT		Supernus Pharmaceuticals, Inc. - SUPN	62% 4.79K to 7.78K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 5:00 PM View:	23-Feb-24 Payment of Exercise ($16.48K)	Rubin Jonathan SVP, Chief Medical Officer		Supernus Pharmaceuticals, Inc. - SUPN	63% 2.85K to 4.64K	0	0	--	--	Show Txns Hide Txns

Supernus Pharmaceuticals, Inc. (SUPN)

Last Year

29-Apr-23 -- 28-Apr-24

Company Sentiment

Other

Other

Two Year Chart

29-Apr-22 -- 28-Apr-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	($162.22K)	$31.59